statistiche ricercatore

TANDA, MARIA LAURA PIERA

Distribuzione geografica

Continente	#
NA - Nord America	12.379
EU - Europa	6.397
AS - Asia	3.848
SA - Sud America	630
AF - Africa	64
Continente sconosciuto - Info sul continente non disponibili	15
OC - Oceania	14
AN - Antartide	1
Totale	23.348

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	12.222
IT - Italia	3.086
SG - Singapore	1.384
UA - Ucraina	864
CN - Cina	719
SE - Svezia	604
HK - Hong Kong	526
BR - Brasile	510
VN - Vietnam	483
DE - Germania	446
TR - Turchia	437
IE - Irlanda	321
GB - Regno Unito	290
FI - Finlandia	246
RU - Federazione Russa	187
CA - Canada	90
JP - Giappone	76
IN - India	74
FR - Francia	63
MX - Messico	60
PL - Polonia	48
AR - Argentina	42
AT - Austria	41
CZ - Repubblica Ceca	35
NL - Olanda	33
ZA - Sudafrica	32
ES - Italia	31
BD - Bangladesh	25
BE - Belgio	21
EC - Ecuador	21
CH - Svizzera	19
CL - Cile	19
LT - Lituania	17
IQ - Iraq	16
EU - Europa	14
ID - Indonesia	13
PK - Pakistan	13
AE - Emirati Arabi Uniti	12
IL - Israele	11
UZ - Uzbekistan	9
VE - Venezuela	9
NZ - Nuova Zelanda	8
PE - Perù	8
RO - Romania	8
CO - Colombia	7
NP - Nepal	7
PY - Paraguay	7
AU - Australia	6
KR - Corea	6
MA - Marocco	6
MY - Malesia	6
EG - Egitto	5
BY - Bielorussia	4
KE - Kenya	4
KG - Kirghizistan	4
TH - Thailandia	4
TN - Tunisia	4
UY - Uruguay	4
BG - Bulgaria	3
DK - Danimarca	3
HR - Croazia	3
HU - Ungheria	3
JM - Giamaica	3
MD - Moldavia	3
PH - Filippine	3
PT - Portogallo	3
RS - Serbia	3
SA - Arabia Saudita	3
TW - Taiwan	3
BA - Bosnia-Erzegovina	2
BH - Bahrain	2
BO - Bolivia	2
CG - Congo	2
CI - Costa d'Avorio	2
EE - Estonia	2
HN - Honduras	2
IR - Iran	2
JO - Giordania	2
MK - Macedonia	2
SK - Slovacchia (Repubblica Slovacca)	2
SN - Senegal	2
A2 - ???statistics.table.value.countryCode.A2???	1
AQ - Antartide	1
AZ - Azerbaigian	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
ET - Etiopia	1
GA - Gabon	1
GR - Grecia	1
KW - Kuwait	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
LV - Lettonia	1
MO - Macao, regione amministrativa speciale della Cina	1
MU - Mauritius	1
NG - Nigeria	1
NO - Norvegia	1
PS - Palestinian Territory	1
QA - Qatar	1
Totale	23.343

Salva come PNG Salva come JPEG

Città	#
Milan	2.076
Fairfield	1.409
Dallas	1.220
Ashburn	1.101
Woodbridge	831
Singapore	766
Chandler	737
Jacksonville	684
Houston	672
Seattle	563
Wilmington	527
Hong Kong	519
Cambridge	451
Dearborn	367
Ann Arbor	354
Nyköping	322
Dublin	305
Princeton	302
Beijing	234
Izmir	216
Boardman	211
Rome	170
Dong Ket	164
Los Angeles	155
New York	143
Chicago	126
The Dalles	126
San Diego	102
Como	101
London	93
San Mateo	78
Munich	74
Tokyo	72
São Paulo	69
Ogden	60
Washington	57
Santa Clara	52
Helsinki	48
Redmond	48
Warsaw	46
Ho Chi Minh City	43
Hanoi	41
Hefei	39
Frankfurt am Main	36
Varese	34
Brno	33
Kunming	33
Montreal	33
Denver	31
Toronto	30
Buffalo	29
Mexico City	29
Guangzhou	27
Phoenix	27
Atlanta	26
Düsseldorf	26
Orem	26
Johannesburg	25
Poplar	25
San Francisco	25
Chennai	24
Shanghai	24
Vienna	24
Turku	23
Brooklyn	22
Brussels	21
Nanjing	21
Norwalk	21
Salt Lake City	21
Nuremberg	20
Cavaria con Premezzo	19
Stockholm	19
Berlin	17
Council Bluffs	17
Manchester	17
North Bergen	17
Jinan	16
Tampa	16
Belo Horizonte	15
Boston	15
Elk Grove Village	13
Turin	13
Ankara	12
Amsterdam	11
Charlotte	11
Falkenstein	11
Haiphong	11
Istanbul	11
Nanchang	11
Paris	11
Querétaro	11
Verona	11
Des Moines	10
Pune	10
Rio de Janeiro	10
Changsha	9
Columbus	9
Curitiba	9
Guayaquil	9
Kilburn	9
Totale	16.870

Salva come PNG Salva come JPEG

Nome	#
Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma	237
Simultaneous medullary and papillary thyroid cancer: two case reports.	234
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study	232
Masked hypertension in newly diagnosed hypothyroidism: a pilot study	228
Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved?	227
The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study	225
Epidemiology, natural history, risk factors, and prevention of graves’ orbitopathy	225
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management	220
Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role?	217
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study	211
Breast cancer and thyroid diseases: analysis of 867 consecutive cases	204
Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature	204
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?	200
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity	199
Nutrizione iodica e ipertiroidismo: quello che c’è da sapere	197
Pituitary apoplexy during pregnancy: A rare, but dangerous headache	197
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	197
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy?	194
Continuous monitoring of the recurrent laryngeal nerve in thyroid surgery: a critical appraisal	191
Can a patient-tailored treatment approach for Graves' disease reduce mortality?	189
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe	189
Outcome prediction of treatment of Graves' hyperthyroidism with antithyroid drugs	188
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study	186
Physical performance in newly diagnosed hypothyroidism: a pilot study	185
Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective study	184
Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction	182
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial	182
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study	181
Minimally invasive follicular thyroid cancer (MIFTC) - A consensus report of the European Society of Endocrine Surgeons (ESES)	180
Skeletal health in patients with differentiated thyroid carcinoma	180
Case report: multiple electrolyte disturbance with severe neurological manifestations induced by chronic use of PPIs	179
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)	178
Medullary thyroid carcinoma: surgical treatment advances	175
Iodine supplementation in women of reproductive age: a survey of clinical practice among Italian gynecologists and midwives	174
An update on medical management of Graves' ophthalmopathy	173
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal	173
Thyroid cancer with tracheal invasion: A pathological estimation	173
Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association	171
Multidisciplinary Management of Intrathoracic Goiter: A Case Report	171
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.	170
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group	169
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study	166
Thyroid hormone treatment for differentiated thyroid carcinoma: What drug, how long, what dose?	165
Shortening Hospital Stay for Thyroid Surgery.	164
Pituitary in black—hypopituitarism secondary to hemosiderosis	163
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center	162
Novel treatment modalities for Graves' orbitopathy	158
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment	158
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy	156
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels:studies in vivo by color flow Doppler sonography	156
Orbital radiotherapy for Graves' ophthalmopathy	156
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy	155
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study	155
Graves' ophthalmopathy	155
An update on the pharmacological management of hyperthyroidism due to Graves' disease	152
Treating Graves' orbitopathy: where are we?	151
Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature	151
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy	150
Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis prior to thyroidectomy	149
Radioiodine and thyroid-associated ophthalmopathy	149
Medullary thyroid carcinoma: surgical treatment advances	149
Amiodarone and the thyroid	149
Analisi dei costi	149
Cigarette smoking and the thyroid	148
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European Endocrinologists	147
Orbital radiotherapy for Graves' ophthalmopathy	146
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement.	146
Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists' perspectives.	145
Thyroid autoimmunity and environment	144
Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications	143
Relationship between management of hyperthyroidism and course of the ophthalmopathy	143
Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations	143
Orbital radiotherapy for Graves' ophthalmopathy	143
Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding?	143
Amyloid goiter	143
Management of thyroid eye disease	142
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?	142
Recent developments in the follow-up, prevention and management of complications in thyroid surgery	141
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease	141
Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions	140
Efficacy and safety of orbital radiotherapy for Graves' orbitopathy	137
Novel approaches to the management of Graves' ophthalmopathy	137
Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study	137
La prevenzione dell'oftalmopatia basedowiana	135
Cigarette smoking and treatment outcomes in Graves' ophthalmopathy	135
Amiodarone-unduced thyrotoxicosis. A review	135
Currently available somatostatin analogs are not good for Graves' orbitopathy	134
Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying	134
Position statement of the Microbiota International Clinical Society	132
Novel immunomodulating agents for Graves orbitopathy	131
Orbital decompression in Graves' ophthalmopathy by medial and lateral wall removal	131
Smoking and the Thyroid	131
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment	131
Solitary intrathyroidal metastasis of renal clear cell carcinoma in a toxic substernal multinodular goiter.	129
When primary hyperparathyroidism comes as good news	128
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	125
The iodine nutritional status in the Italian population: data from the Italian National Observatory for Monitoring Iodine Prophylaxis (OSNAMI) (period 2015–2019)	123
Prevalence and natural history of Graves' orbitopathy in the XXI century	122
Autoimmune Thyroid Disease	122
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	117
Totale	16.435

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	102.630
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	102.630

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	2.015	0	0	0	0	0	314	261	294	365	170	243	368
2021/2022	1.829	176	169	89	71	111	139	117	88	246	291	128	204
2022/2023	2.201	272	139	170	230	158	486	16	265	264	82	52	67
2023/2024	3.560	531	536	544	653	643	333	19	41	95	46	17	102
2024/2025	2.905	14	26	435	126	100	145	135	210	306	230	366	812
2025/2026	4.773	624	737	998	1.184	800	430	0	0	0	0	0	0
Totale													23.654